Drug Profile
APD 209
Alternative Names: ADE CTP-12-001; APD-209; Trisialic acid compoundLatest Information Update: 01 Nov 2019
Price :
$50
*
At a glance
- Originator Adenovir Pharma
- Class Eye disorder therapies; Sialic acids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Infectious keratoconjunctivitis